Antiprogestin-Mediated Inactivation of Cytochrome P450 3A4 | Citedby Results | Pharmacology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Antiprogestin-Mediated Inactivation of Cytochrome P450 3A4

Pharmacology (1998) 56 (3): 150–157.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Clinical Pharmacology at the Intersection of Women's Health and Regulation: Drug Development Considerations for Uterine Fibroids

Jihong Shon
Peng Zou
Doanh Tran
Shirley K. Seo
Yanhui Lu

The Journal of Clinical Pharmacology (2020) 60 (S2)

A single-dose PK study of onapristone including the effect of food on absorption

Keyvan Rezai
Didier Chassard
Caroline Denot
Stefan Proniuk
Alexander Zukiwski
Erard Gilles
Haydeé L. Ramos
Alain Patat
Alice Bexon
François Lokiec

Cancer Chemotherapy and Pharmacology (2015) 76 (1): 171.

Metabolic Activation of Mifepristone [RU486; 17β-Hydroxy-11β-(4-dimethylaminophenyl)-17α-(1-propynyl)-estra-4,9-dien-3-one] by Mammalian Cytochromes P450 and the Mechanism-Based Inactivation of Human CYP2B6

Hsia-lien Lin
Haoming Zhang
Paul F. Hollenberg

Journal of Pharmacology and Experimental Therapeutics (2009) 329 (1): 26.

Cytochrome P450 Inactivation by Pharmaceuticals and Phytochemicals: Therapeutic Relevance

William W. Johnson

Drug Metabolism Reviews (2008) 40 (1): 101.

Toxicological Significance of Mechanism-Based Inactivation of Cytochrome P450 Enzymes by Drugs

Yasuhiro Masubuchi
Toshiharu Horie

Critical Reviews in Toxicology (2007) 37 (5): 389.

Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs

Shufeng Zhou
Sui Yung Chan
Boon Cher Goh
Eli Chan
Wei Duan
Min Huang
Howard L McLeod

Clinical Pharmacokinetics (2005) 44 (3): 279.

AUTOMATED SCREENING WITH CONFIRMATION OF MECHANISM-BASED INACTIVATION OF CYP3A4, CYP2C9, CYP2C19, CYP2D6, AND CYP1A2 IN POOLED HUMAN LIVER MICROSOMES

Heng-Keang Lim
Nicholas Duczak
Linda Brougham
Michael Elliot
Krupa Patel
Kelvin Chan

Drug Metabolism and Disposition (2005) 33 (8): 1211.

Summary of information on human CYP enzymes: human P450 metabolism data

Slobodan Rendic

Drug Metabolism Reviews (2002) 34 (1-2): 83.

Mifepristone

Renee M DeHart
M Shawn Morehead

Annals of Pharmacotherapy (2001) 35 (6): 707.

Drug interactions/P450

Lori E. Shapiro
Neil H. Shear

Current Problems in Dermatology (2001) 13 (3): 141.

Mechanism-based inhibition of rat liver microsomal diazepam C3-hydroxylase by mifepristone associated with loss of spectrally detectable cytochrome P450

Paul E.B. Reilly
Rebecca J. Gomi
Steven R. Mason

Chemico-Biological Interactions (1999) 118 (1): 39.